Kura Oncology Inc’s recent filing unveils that its Chief Legal Officer Bair Teresa Brophy unloaded Company’s shares for reported $9292.0 on May 19 ’25. In the deal valued at $5.96 per share,1,559 shares were sold. As a result of this transaction, Bair Teresa Brophy now holds 107,948 shares worth roughly $0.68 million.
Then, FORD KATHLEEN sold 1,558 shares, generating $9,777 in total proceeds. Upon selling the shares at $6.28, the Chief Operating Officer now owns 21,367 shares.
Before that, FORD KATHLEEN bought 1,558 shares. Kura Oncology Inc shares valued at $9,286 were divested by the Officer at a price of $5.96 per share.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Monday, Kura Oncology Inc [NASDAQ:KURA] saw its stock jump 10.72% to $6.30. Over the last five days, the stock has gained 11.70%. Kura Oncology Inc shares have fallen nearly -27.67% since the year began. Nevertheless, the stocks have fallen -69.22% over the past one year. While a 52-week high of $23.48 was reached on 02/05/25, a 52-week low of $5.41 was recorded on 04/07/25. SMA at 50 days reached $6.22, while 200 days put it at $11.55.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 5.89, which if violated will result in even more drops to 5.48. On the upside, there is a resistance level at 6.58. A further resistance level may holdings at 6.87. The Relative Strength Index (RSI) on the 14-day chart is 54.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.39%. Stochastics %K at 44.34% indicates the stock is a holding.
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
